Revolution Medicines, Inc. (RVMD)
200.38
+4.46
(+2.28%)
USD |
NASDAQ |
Sep 17, 11:03
Revolution Medicines Total Return Level : 195.92 for Sept. 16, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 16, 2026 | 195.92 |
| September 15, 2026 | 204.86 |
| September 14, 2026 | 205.11 |
| September 11, 2026 | 203.77 |
| September 10, 2026 | 203.35 |
| September 09, 2026 | 207.68 |
| September 08, 2026 | 207.32 |
| September 04, 2026 | 210.02 |
| September 03, 2026 | 210.87 |
| September 02, 2026 | 209.23 |
| September 01, 2026 | 209.87 |
| August 31, 2026 | 205.57 |
| August 28, 2026 | 207.88 |
| August 27, 2026 | 221.15 |
| August 26, 2026 | 215.44 |
| August 25, 2026 | 211.38 |
| August 24, 2026 | 211.58 |
| August 21, 2026 | 209.46 |
| August 20, 2026 | 211.74 |
| August 19, 2026 | 214.66 |
| August 18, 2026 | 216.00 |
| August 17, 2026 | 212.00 |
| August 14, 2026 | 203.71 |
| August 13, 2026 | 202.00 |
| August 12, 2026 | 205.26 |
| Date | Value |
|---|---|
| August 11, 2026 | 205.55 |
| August 10, 2026 | 206.97 |
| August 07, 2026 | 205.15 |
| August 06, 2026 | 197.81 |
| August 05, 2026 | 197.30 |
| August 04, 2026 | 193.46 |
| August 03, 2026 | 182.45 |
| July 31, 2026 | 187.53 |
| July 30, 2026 | 192.17 |
| July 29, 2026 | 180.92 |
| July 28, 2026 | 183.86 |
| July 27, 2026 | 188.07 |
| July 24, 2026 | 189.23 |
| July 23, 2026 | 188.75 |
| July 22, 2026 | 183.03 |
| July 21, 2026 | 183.29 |
| July 20, 2026 | 180.39 |
| July 17, 2026 | 186.16 |
| July 16, 2026 | 179.18 |
| July 15, 2026 | 184.44 |
| July 14, 2026 | 184.97 |
| July 13, 2026 | 183.95 |
| July 10, 2026 | 186.88 |
| July 09, 2026 | 191.13 |
| July 08, 2026 | 189.77 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Erasca, Inc. | 15.36 |
| Moderna, Inc. | 145.62 |
| Tango Therapeutics, Inc. | 23.35 |
| Arrowhead Pharmaceuticals, Inc. | 65.79 |
| Intellia Therapeutics, Inc. | 11.49 |